Evidence map›Paper›PMID 41042379›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025

The Legacy of Chattel Slavery and Its Association with Prostate Cancer Incidences in the Southeastern United States.

Maheetha C Bharadwaj, Sarah K Holt, Hari S Iyer, Jenney R Lee, Erika M Wolff, Timothy R Rebbeck, John L Gore, Yaw A Nyame

Abstract readHistorical Article
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maheetha C BharadwajDepartment of Urology, University of Washington School of Medicine, Seattle, Washington.ORCID 0009-0005-3660-5022
Sarah K HoltDepartment of Urology, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0001-6302-5502
Hari S IyerSection of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, New Brunswick, New Jersey.ORCID 0000-0002-7596-9049
Jenney R LeeDepartment of Urology, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0003-4667-6148
Erika M WolffDepartment of Urology, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0003-1160-374X
Timothy R RebbeckDana Farber Cancer Institute, TH Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-4799-1900
John L GoreDepartment of Urology, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0002-2847-5062
Yaw A NyameDepartment of Urology, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0002-8799-6749

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI John Kyung Lee · 2002 to 2026
$58.1M
Andy Hill CARE Fund (CARE) FY23-POP-02National Cancer Institute (NCI) P50 CA097186-17NCI NIH HHS P50 CA097186U.S. Department of Defense (DOD) CDMRP W81XWH211053Zhu Family Center for Global Cancer Prevention
6 · The paper itself

Abstract

backgroundPresent-day disparities in prostate cancer outcomes are a direct result of major historical events, such as chattel slavery. Few studies have evaluated the association between the legacy of historical racism and prostate cancer, a disease with a wide health disparity globally. In this study, we assess the relationship between county-level historical chattel slavery in 1860 and prostate cancer incidences in 2018 among Black and White individuals.

methodsProstate cancer incidences, socioeconomic variables, and 1860 slave data were all obtained from publicly available datasets. Our primary exposure was county-level density of enslaved people in 1860. Our primary dependent variable was prostate cancer incidence per 100,000. We used Poisson log-linear regression models to estimate the difference in county-level cancer counts per 10% increase in enslaved individuals in a county, adjusting for age and numerous social determinants of health.

resultsCounty-level density of enslaved people correlated with various present-day social determinants of health. In our multivariable adjusted model, increased county-level enslaved populations in 1860 were independently associated with a significant increase in 2018 county-level prostate cancer incidences for both White and Black individuals.

conclusionsOur results indicate that the presence of county-level chattel slavery was significantly associated with poorer present-day social determinants of health and increased prostate cancer incidences, regardless of race. IMPACT: Addressing health inequities requires the acknowledgment of the role historical chattel slavery plays in health disparities affecting marginalized and low socioeconomic communities in America.

Indexed as

EnslavementProstatic NeoplasmsAgedBlack or African AmericanHealth Status DisparitiesHistory, 19th CenturyHumansIncidenceMaleMiddle AgedSocioeconomic FactorsSoutheastern United StatesWhite

Identifiers

PMID41042379
PMCPMC12577743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.